Vivio AS (Aortic Stenosis) Detection Study
NCT04066634 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2021-08-02
Summary
Evaluate the sensitivity and specificity of the Vivio System when used as an aid in the identification of heart sounds associated with severe aortic stenosis.
Conditions
- Aortic Stenosis
Interventions
- DEVICE
-
Vivio System
The Vivio Analysis Software is an analysis software that assists in identifying suspected systolic murmurs associated with aortic stenosis. The Vivio Analysis Software is used with the Vivio System, a non-invasive device used for the detection and amplification of sounds from the heart and arteries.
Sponsors & Collaborators
-
Avicena LLC
lead INDUSTRY
Principal Investigators
-
Sean Brady, JD · Avicena LLC
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-04-02
- Primary Completion
- 2019-10-29
- Completion
- 2019-10-29
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Venus-Vitae Pivotal Study Smart-Align Study
NCT05991271 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
NCT01240902 ·Status: COMPLETED ·Phase: NA
-
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
NCT05712161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Safety and Accuracy of the Microtech System in Patients Undergoing Left Ventricular Assist Device Implantation
NCT06682910 ·Status: RECRUITING ·Phase: NA
-
EFS of the DUO System for Tricuspid Regurgitation
NCT05913908 ·Status: RECRUITING ·Phase: NA
-
INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study
NCT04902053 ·Status: SUSPENDED
-
TranScatheter Aortic Valve RepLacement System US Feasibility Trial
NCT01932099 ·Status: UNKNOWN ·Phase: PHASE2
-
The Medtronic TAVR 2.0 US Clinical Study
NCT02738853 ·Status: COMPLETED ·Phase: NA
-
Trevisio Post-Approval Study
NCT04433520 ·Status: COMPLETED
-
DurAVR™ THV System: First-In-Human Study
NCT05182307 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
NCT00512005 ·Status: UNKNOWN ·Phase: PHASE1
-
Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary Hypertension
NCT05001711 ·Status: COMPLETED ·Phase: NA
-
Medtronic Evolut™ EXPAND TAVR I Feasibility Study
NCT04639258 ·Status: TERMINATED ·Phase: NA
-
VIenna Pilot Study for Automated Annular Suturing Technology
NCT04659655 ·Status: UNKNOWN ·Phase: NA
-
Corheart 6 LVAS Study
NCT05876000 ·Status: RECRUITING ·Phase: NA
-
Indicor Validation
NCT03430102 ·Status: COMPLETED
-
Prospective Study of the BioVentrix PliCath HF™ System for the Treatment of Ischemic Cardiomyopathy
NCT01568138 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
NCT07194265 ·Status: RECRUITING ·Phase: NA
-
Assessment of Myocardial Disease in Man Using Novel Non-invasive Diagnostic Tools
NCT00507312 ·Status: TERMINATED ·Phase: PHASE1
-
Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study
NCT06583876 ·Status: RECRUITING ·Phase: NA
-
Post-market Safety and Performance Outcomes of the VIVERE® Bovine Pericardial Bioprosthetic Valve
NCT06959836 ·Status: COMPLETED
-
Safety and Efficacy Study of the BioVentrix PliCath HF System
NCT01568164 ·Status: COMPLETED ·Phase: NA
-
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
NCT05848284 ·Status: RECRUITING ·Phase: NA
-
The V-Wave Shunt: FIM Safety and Feasibility Study
NCT01965015 ·Status: COMPLETED ·Phase: NA
-
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
NCT06212193 ·Status: RECRUITING ·Phase: NA